These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 38760977)

  • 1. Associations of clinical, psychological, and sociodemographic characteristics and ecological momentary assessment completion in the 10-week Hypo-METRICS study: Hypoglycaemia MEasurements ThResholds and ImpaCtS.
    Zaremba N; Martine-Edith G; Divilly P; Søholm U; Broadley M; Ali N; Abbink EJ; de Galan B; Cigler M; Mader JK; Brosen J; Pedersen-Bjergaard U; Vaag A; Evans M; Renard E; McCrimmon RJ; Heller S; Speight J; Pouwer F; Amiel SA; Choudhary P;
    Diabet Med; 2024 Aug; 41(8):e15345. PubMed ID: 38760977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigating the day-to-day impact of hypoglycaemia in adults with type 1 or type 2 diabetes: design and validation protocol of the Hypo-METRICS application.
    Søholm U; Broadley M; Zaremba N; Divilly P; Nefs G; Mahmoudi Z; de Galan B; Pedersen-Bjergaard U; Brennan A; Pollard DJ; McCrimmon RJ; A Amiel S; Hendrieckx C; Speight J; Choudhary P; Pouwer F;
    BMJ Open; 2022 Feb; 12(2):e051651. PubMed ID: 35105572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychometric properties of an innovative smartphone application to investigate the daily impact of hypoglycemia in people with type 1 or type 2 diabetes: The Hypo-METRICS app.
    Søholm U; Broadley M; Zaremba N; Divilly P; Nefs G; Carlton J; Mader JK; Baumann PM; Gomes M; Martine-Edith G; Pollard DJ; Rath D; Heller S; Pedersen-Bjergaard U; McCrimmon RJ; Renard E; Evans M; de Galan B; Forkmann T; Amiel SA; Hendrieckx C; Speight J; Choudhary P; Pouwer F;
    PLoS One; 2023; 18(3):e0283148. PubMed ID: 36930585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypo-METRICS: Hypoglycaemia-MEasurement, ThResholds and ImpaCtS-A multi-country clinical study to define the optimal threshold and duration of sensor-detected hypoglycaemia that impact the experience of hypoglycaemia, quality of life and health economic outcomes: The study protocol.
    Divilly P; Zaremba N; Mahmoudi Z; Søholm U; Pollard DJ; Broadley M; Abbink EJ; de Galan B; Pedersen-Bjergaard U; Renard E; Evans M; Speight J; Brennan A; McCrimmon RJ; Müllenborn M; Heller S; Seibold A; Mader JK; Amiel SA; Pouwer F; Choudhary P;
    Diabet Med; 2022 Sep; 39(9):e14892. PubMed ID: 35633291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing the Content Validity, Acceptability, and Feasibility of the Hypo-METRICS App: Survey and Interview Study.
    Søholm U; Zaremba N; Broadley M; Axelsen JL; Divilly P; Martine-Edith G; Amiel SA; Mader JK; Pedersen-Bjergaard U; McCrimmon RJ; Renard E; Evans M; de Galan B; Heller S; Hendrieckx C; Choudhary P; Speight J; Pouwer F;
    JMIR Diabetes; 2023 Sep; 8():e42100. PubMed ID: 37773626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of flash glucose monitoring on hypoglycaemia in adults with type 1 diabetes managed with multiple daily injection therapy: a pre-specified subgroup analysis of the IMPACT randomised controlled trial.
    Oskarsson P; Antuna R; Geelhoed-Duijvestijn P; Krӧger J; Weitgasser R; Bolinder J
    Diabetologia; 2018 Mar; 61(3):539-550. PubMed ID: 29273897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized controlled pilot study of continuous glucose monitoring and flash glucose monitoring in people with Type 1 diabetes and impaired awareness of hypoglycaemia.
    Reddy M; Jugnee N; El Laboudi A; Spanudakis E; Anantharaja S; Oliver N
    Diabet Med; 2018 Apr; 35(4):483-490. PubMed ID: 29230878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Comparison of the Rates of Clock-Based Nocturnal Hypoglycemia and Hypoglycemia While Asleep Among People Living with Diabetes: Findings from the Hypo-METRICS Study.
    Martine-Edith G; Divilly P; Zaremba N; Søholm U; Broadley M; Baumann PM; Mahmoudi Z; Gomes M; Ali N; Abbink EJ; de Galan B; Brøsen J; Pedersen-Bjergaard U; Vaag AA; McCrimmon RJ; Renard E; Heller S; Evans M; Cigler M; Mader JK; Speight J; Pouwer F; Amiel SA; Choudhary P; Hypo-Resolve FT
    Diabetes Technol Ther; 2024 Jul; 26(7):433-441. PubMed ID: 38386436
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults With Type 1 Diabetes: A Randomized Clinical Trial.
    Pratley RE; Kanapka LG; Rickels MR; Ahmann A; Aleppo G; Beck R; Bhargava A; Bode BW; Carlson A; Chaytor NS; Fox DS; Goland R; Hirsch IB; Kruger D; Kudva YC; Levy C; McGill JB; Peters A; Philipson L; Philis-Tsimikas A; Pop-Busui R; Shah VN; Thompson M; Vendrame F; Verdejo A; Weinstock RS; Young L; Miller KM;
    JAMA; 2020 Jun; 323(23):2397-2406. PubMed ID: 32543682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between recent exposure to continuous glucose monitoring-recorded hypoglycaemia and counterregulatory and symptom responses to subsequent controlled hypoglycaemia in people with type 1 diabetes.
    Svensson CH; Fabricius TW; Verhulst CEM; Kristensen PL; Tack CJ; Heller SR; Amiel SA; McCrimmon RJ; Evans M; Holst JJ; de Galan BE; Pedersen-Bjergaard U;
    Diabetes Obes Metab; 2024 Aug; 26(8):3213-3222. PubMed ID: 38774963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential associations of risk factors with severe and non-severe hypoglycaemia: the Hypoglycaemia Assessment Tool prospective observational study in people with insulin-treated type 1 diabetes and type 2 diabetes.
    He Y; Kunutsor SK; Kingsnorth AP; Gillies C; Choudhary P; Khunti K; Zaccardi F
    Diabetes Obes Metab; 2024 Aug; 26(8):3361-3370. PubMed ID: 38826105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous glucose monitoring for patients with type 1 diabetes and impaired awareness of hypoglycaemia (IN CONTROL): a randomised, open-label, crossover trial.
    van Beers CA; DeVries JH; Kleijer SJ; Smits MM; Geelhoed-Duijvestijn PH; Kramer MH; Diamant M; Snoek FJ; Serné EH
    Lancet Diabetes Endocrinol; 2016 Nov; 4(11):893-902. PubMed ID: 27641781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High intensity interval training as a novel treatment for impaired awareness of hypoglycaemia in people with type 1 diabetes (HIT4HYPOS): a randomised parallel-group study.
    Farrell CM; McNeilly AD; Hapca S; Fournier PA; Jones TW; Facchinetti A; Cappon G; West DJ; McCrimmon RJ
    Diabetologia; 2024 Feb; 67(2):392-402. PubMed ID: 38010533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-time continuous glucose monitoring in adults with type 1 diabetes and impaired hypoglycaemia awareness or severe hypoglycaemia treated with multiple daily insulin injections (HypoDE): a multicentre, randomised controlled trial.
    Heinemann L; Freckmann G; Ehrmann D; Faber-Heinemann G; Guerra S; Waldenmaier D; Hermanns N
    Lancet; 2018 Apr; 391(10128):1367-1377. PubMed ID: 29459019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous glucose monitoring detected hypoglycaemia in the Treating to Target in Type 2 Diabetes Trial (4-T).
    Levy JC; Davies MJ; Holman RR;
    Diabetes Res Clin Pract; 2017 Sep; 131():161-168. PubMed ID: 28750219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations between daily step count classifications and continuous glucose monitoring metrics in adults with type 1 diabetes: analysis of the Type 1 Diabetes Exercise Initiative (T1DEXI) cohort.
    Turner LV; Marak MC; Gal RL; Calhoun P; Li Z; Jacobs PG; Clements MA; Martin CK; Doyle FJ; Patton SR; Castle JR; Gillingham MB; Beck RW; Rickels MR; Riddell MC;
    Diabetologia; 2024 Jun; 67(6):1009-1022. PubMed ID: 38502241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Switching from Flash Glucose Monitoring to Continuous Glucose Monitoring on Hypoglycemia in Adults with Type 1 Diabetes at High Hypoglycemia Risk: The Extension Phase of the I HART CGM Study.
    Reddy M; Jugnee N; Anantharaja S; Oliver N
    Diabetes Technol Ther; 2018 Nov; 20(11):751-757. PubMed ID: 30265562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of initiating use of an insulin pump in adults with type 1 diabetes using multiple daily insulin injections and continuous glucose monitoring (DIAMOND): a multicentre, randomised controlled trial.
    Beck RW; Riddlesworth TD; Ruedy KJ; Kollman C; Ahmann AJ; Bergenstal RM; Bhargava A; Bode BW; Haller S; Kruger DF; McGill JB; Polonsky W; Price D; Toschi E;
    Lancet Diabetes Endocrinol; 2017 Sep; 5(9):700-708. PubMed ID: 28711468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time With Diabetes Distress and Glycemia-Specific Distress: New Patient-Reported Outcome Measures for the Psychosocial Burden of Diabetes Using Ecological Momentary Assessment in an Observational Study.
    Ehrmann D; Schmitt A; Priesterroth L; Kulzer B; Haak T; Hermanns N
    Diabetes Care; 2022 Jul; 45(7):1522-1531. PubMed ID: 35613338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial.
    Beck RW; Riddlesworth T; Ruedy K; Ahmann A; Bergenstal R; Haller S; Kollman C; Kruger D; McGill JB; Polonsky W; Toschi E; Wolpert H; Price D;
    JAMA; 2017 Jan; 317(4):371-378. PubMed ID: 28118453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.